The VIS Steering Committee will be convened to provide expert advice across multiple perspectives and deliberations and will provide technical input into the development of Gavi Secretariat’s recommendations to the Programme and Policy Committee…

The COVAX Facility is seeking expressions of interest from the subject matter experts to join the COVAX Independent Product Group. The Independent Product Group (“IPG”) is established to provide scientific advice on COVID-19 vaccines and make…

Today’s launch marks the introduction of the rotavirus vaccine, which protects against rotavirus-related diarrhoeal disease, into Nigeria’s routine immunisation programme.

The preventive mass vaccination campaign will target nearly the entire population, ranging from 9 months to 60 years old in 11 departments in Congo.

New analysis of the state of routine immunisation in lower-income countries underlines impact of COVID-19 pandemic, but signs of recovery are emerging.